ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Total Liabilities & Equity
ESSA Pharma Inc
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Total Liabilities & Equity
$144.5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Liabilities & Equity
$580.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Liabilities & Equity
$253.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Liabilities & Equity
$285.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Liabilities & Equity
$516.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Spectral Medical Inc
TSX:EDT
|
Total Liabilities & Equity
CA$4.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
See Also
What is ESSA Pharma Inc's Total Liabilities & Equity?
Total Liabilities & Equity
144.5m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Total Liabilities & Equity amounts to 144.5m USD.
What is ESSA Pharma Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
61%
Over the last year, the Total Liabilities & Equity growth was -12%. The average annual Total Liabilities & Equity growth rates for ESSA Pharma Inc have been 24% over the past three years , 61% over the past five years .